AM
Publications
41
Views
5 000
Downloads
1 469
Supervised works
0
Items per page
1 - 41 of 41
Title Published in Access level OA Policy Year Views Downloads
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case reportFrontiers in immunology
accessLevelPublic
2024 13 13
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort : a prospective observational cohort studyThe lancet. HIV
accessLevelRestricted
2024 15 0
Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)Bulletin du cancer
accessLevelRestricted
2024 18 0
Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxisTransplant infectious disease
accessLevelPublic
2024 7 10
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivationBlood advances
accessLevelPublic
2024 32 25
Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplantOpen forum infectious diseases
accessLevelPublic
2023 22 12
Myositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies : an unusual presentation of graft-versus-host diseaseLeukemia and lymphoma
accessLevelRestricted
2023 27 1
Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipientsClinical infectious diseases
accessLevelPublic
2023 53 19
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruptionFrontiers in oncology
accessLevelPublic
2023 25 9
CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant RecipientsOpen forum infectious diseases
accessLevelPublic
2023 59 10
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantationLeukemia & lymphoma
accessLevelPublic
2023 24 12
Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant RecipientsAntimicrobial agents and chemotherapy
accessLevelPublic
2023 52 74
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell TransplantOpen forum infectious diseases
accessLevelPublic
2023 24 16
SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant RecipientsVaccines
accessLevelPublic
2023 46 18
Modalités et impact de la cryopréservation des greffons allogéniques en contexte pandémique : recommandations de la SFGM-TCBulletin du cancer
accessLevelRestricted
2023 27 0
Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?Open forum infectious diseases
accessLevelPublic
2022 221 110
Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantationFrontiers in immunology
accessLevelPublic
2022 57 22
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infectionsMycoses
accessLevelPublic
2022 220 101
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective StudyTransplantation and cellular therapy
accessLevelPublic
2022 80 37
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipientsAnnals of oncology
accessLevelPublic
2022 111 30
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?Mycoses
accessLevelPublic
2022 58 15
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationBlood advances
accessLevelPublic
2021 238 77
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graftBone marrow transplantation
accessLevelRestricted
2021 254 0
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipientsBone marrow transplantation
accessLevelRestricted
2021 213 2
Suivi au moyen-terme des patients faisant l’objet d’un traitement par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)Bulletin du cancer
accessLevelRestricted
2021 160 0
Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantationJournal of Fungi
accessLevelPublic
2021 139 81
Successful treatment of central nervous system lymphoproliferative disorder in a kidney-pancreas and stem cell transplanted patient using intrathecal rituximabBMJ case reports
accessLevelRestricted
2021 175 1
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantationLeukemia
accessLevelPublic
2020 329 235
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemiaBone Marrow Transplantation
accessLevelRestricted
2020 115 0
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)Journal of Hematology & Oncology
accessLevelPublic
2020 183 99
Prérequis pour une production académique des cellules CART conforme aux bonnes pratiques pharmaceutiques (BPF). Recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)Bulletin du cancer
accessLevelPublic
2020 167 66
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted GraftsBiology of Blood and Marrow Transplantation
accessLevelPublic
2020 254 167
Procédé de préparation, contrôles de qualité et spécifications des immunosélections CD34+ : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)Bulletin du cancer
accessLevelRestricted
2020 152 0
Successful Treatment of Saksenaea sp. Osteomyelitis by Conservative Surgery and Intradiaphyseal Incorporation of Amphotericin B Cement BeadsAntimicrobial Agents and Chemotherapy
accessLevelRestricted
2019 162 0
Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteriaHaematologica
accessLevelPublic
2019 222 133
Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndromeBone Marrow Transplantation
accessLevelRestricted
2018 384 0
Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemiaHaematologica
accessLevelPublic
2017 169 74
Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemiaLeukemia and Lymphoma
accessLevelRestricted
2016 112 0
Posttraumatic mucormycosis: a nationwide study in France and review of the literatureMedicine (Baltimore)
accessLevelRestricted
2014 125 0
Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institutionLeukemia Research
accessLevelRestricted
2014 143 0
Dynamics of cytomegalovirus populations harbouring mutations in genes UL54 and UL97 in a haematopoietic stem cell transplant recipientJournal of Clinical Virology
accessLevelRestricted
2013 113 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack